Highlights
ASX: BNO       BIONOMICS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.10   0.00 (0.00%)  0.10 - 0.105  466,547

Overview

 
Avg Volume (4 weeks):1,277,609
4 Weeks Range:0.081 - 0.135
4 Weeks Price Volatility (%):
35.19%
52 Weeks Range:0.031 - 0.25
52 Weeks Price Volatility (%):
31.51%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Bionomics Limited is a clinical-stage biopharmaceutical company engaged in discovery and development of drug candidates focused on the treatment of central nervous system (CNS) disorders and cancer by using its platform technologies. The Company's segments include Drug discovery and development, and Contract services. The Drug discovery and development segment includes the discovery, development and commercialization of compounds to match a target product profile. The Contract services segment includes the provision of scientific services on a fee for service basis to both external and internal customers. Its product candidates include BNC210, BNC375, BNC101 and BNC105. The Company provides treatments for CNS disorders, such as anxiety, depression and Alzheimer's Disease. Its oncology approach targets cancer stem cell therapies in solid tumors. Its technologies include ionX and MultiCore. It operates in three geographical areas, such as Australia, France and the United States.

  Be the first to like this.
 


 

440  721  667  2501 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 IMU 0.053+0.008 
 TTB 0.115+0.037 
 NHL 0.069-0.006 
 HMD 0.27+0.055 
 ECT 0.0010.00 
 SRN 0.0030.00 
 CIO 0.0040.00 
 DTR 0.0020.00 
 AZM 0.0320.00 
 KLH 0.0010.00 
Partners & Brokers